UK government rejects proposals for a national formulary for HRT Other rejected recommendations include the introduction of a menopause leave policy as well as making menopause a protected characteristic under the Equality Act 2010.…
Perimenopause: symptoms and management As many as 90% of women with perimenopausal symptoms will seek help. Here, we outline what pharmacists need to know about these symptoms and the available treatments.…
Is HRT overprescribed? Experts are divided on whether the rapid rise in HRT prescriptions, both on the NHS and in the private sector, should be scrutinised more closely.…
Research, CPD and Learning: 2022 in review Celebrating the highlights from 2022 and a look ahead to 2023.…
Mental health considerations in older women An overview of the most common mental health conditions among older women, identifying where pharmacists are best placed to offer support and advice.…
MPs call for national formulary for HRT treatments The All-Party Parliamentary Group on Menopause has also called for HRT prescription costs to be scrapped.…
Herbal medicines in pregnancy Herbal medicines are commonly used by women during pregnancy. This article explains the potential health risks and uncertainties around their use and how pharmacists can provide supporting information for women.…
Should menopause management differ between ethnic groups? Menopause management is not ‘one size fits all’ and effective treatment needs to be tailored to a woman’s individual needs.…
Oral HRT accepted for use across Scotland while availability remains limited in England Bijuve has been been approved for use across Scotland, but it is only available in some local formularies in England, owing to backlogs caused by COVID-19.…
Safety review launched into anti-epileptic medicine topiramate over fears of harm to unborn children The review was prompted by study results that showed there was a two- to four-fold increased risk of developmental disorders or learning difficulties in children exposed to topiramate before birth.…
